Reversed sequential therapy of hirsutism using cyproterone acetate. II. Hormonal analyses.
D015065:17-Hydroxycorticosteroids / Q000627:therapeutic use* / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects; D002849:Chromatography, Gas; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011276:Pregnanediol / Q000652:urine; D011278:Pregnanes / Q000627:therapeutic use*; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D013739:Testosterone / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D011278:Pregnanes; D013739:Testosterone; D004997:Ethinyl Estradiol; D011374:Progesterone; D007986:Luteinizing Hormone; D011276:Pregnanediol